Filing Flows › Champions Oncology (CSBR) › Q1 FY27
Champions Oncology (CSBR) Q1 FY27 earnings results (first quarter fiscal 2027)
10-Q filed Sep 11, 2026
Champions Oncology (CSBR) reported revenue of $15.2M for the first quarter fiscal 2027 (Q1 FY27), +9% from a year earlier and +10% from the quarter before. Operating margin was -2.7%, net loss $426K (2.8% of revenue).
Champions Oncology, Q1 FY27: revenue $15.2M (+9% year over year), operating margin -2.7%, net loss $426K, operating cash flow −$492K. The chart follows the revenue to costs, profit and cash.
| Q1 FY27 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $15.2M | +10% | +9% |
| Operating profit | −$409K | — | — |
| Net earnings | −$426K | — | — |
| Operating cash flow | −$492K | — | -182% |
What changed
Revenue was $15.2M in Q1 FY27, up 9% year over year and up 10% from the previous quarter. Pharmacology services was the largest line at 93% of revenue. Pharmacology services added $926K year over year (up 7%), 75% of the total change. Other TOS revenue declined 60%.
Operating costs exceeded revenue by $409K, an operating margin of -2.7%. Total costs grew 8% against revenue growth of 9%. The fastest-growing cost line was Sales & marketing (+67%). The quarter ended with a net loss of $426K, narrower than the previous quarter's $667K loss.
Operating cash flow was −$492K. Non-cash charges added back $314K of depreciation and amortization and $766K of share-based compensation. Working capital and other items used $1.1M. Capital expenditures of $55K exceeded it, leaving free cash flow of −$547K.
Questions
What was Champions Oncology's revenue in the first quarter fiscal 2027?
Champions Oncology (CSBR) reported revenue of $15.2M for the first quarter fiscal 2027 (Q1 FY27), +9% from a year earlier and +10% from the quarter before.
Was Champions Oncology profitable in the first quarter fiscal 2027?
Operating loss was $409K (-2.7% of revenue) and net loss $426K.
Source: Champions Oncology 10-Q on SEC EDGAR.